Neutrophil Extracellular Traps Contribute to COVID-19 Hyperinflammation and Humoral Autoimmunity

Neutrophil Extracellular Traps Contribute to COVID-19 Hyperinflammation and Humoral Autoimmunity

The coronavirus disease 2019 (COVID-19) is related to enhanced production of NETs, and autoimmune/autoinflammatory phenomena. We evaluated the proportion of low-density granulocytes (LDG) by flow cytometry, and their capacity to produce NETs was compared with that of conventional neutrophils. NETs a...

Full description

Bibliographic Details
Main Authors:	Jiram Torres-Ruiz, Abdiel Absalón-Aguilar, Miroslava Nuñez-Aguirre, Alfredo Pérez-Fragoso, Daniel Alberto Carrillo-Vázquez, José Luis Maravillas-Montero, Nancy R. Mejía-Domínguez, Luis Llorente, Beatriz Alcalá-Carmona, Jaquelin Lira-Luna, Carlos Núñez-Álvarez, Guillermo Juárez-Vega, David Meza-Sánchez, Thierry Hernández-Gilsoul, Miguel Tapia-Rodríguez, Diana Gómez-Martín
Format:	Article
Language:	English
Published:	MDPI AG 2021-09-01
Series:	Cells
Subjects:	COVID-19 SARS-CoV-2 NETs LDG LL-37 HMGB1
Online Access:	https://www.mdpi.com/2073-4409/10/10/2545

Similar Items

Role of antimicrobial peptide cathelicidin in thrombosis and thromboinflammation
by: Qing Zhang, et al.
Published: (2023-04-01)

The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent
by: Kylen E. Ridyard, et al.
Published: (2021-05-01)

Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy
by: Fatai Lu, et al.
Published: (2022-08-01)

Serum LL‐37 and inflammatory cytokines levels in psoriasis
by: Juanfeng Lao, et al.
Published: (2023-03-01)

Alarmins, COVID-19 and comorbidities
by: Eleonora Di Salvo, et al.
Published: (2021-01-01)

Citrullination-Resistant LL-37 Is a Potent Antimicrobial Agent in the Inflammatory Environment High in Arginine Deiminase Activity
by: Danuta Bryzek, et al.
Published: (2020-11-01)

LL-37 Might Promote Local Invasion of Melanoma by Activating Melanoma Cells and Tumor-Associated Macrophages
by: Kentaro Ohuchi, et al.
Published: (2023-03-01)

Evaluating the Antiviral Activities of Human Cathelicidin LL-37 Peptide Against Rotavirus in Vitro
by: Zohreh Hosseini, et al.
Published: (2019-08-01)

The Role of Antimicrobial Peptides in Influenza Virus Infection and Their Potential as Antiviral and Immunomodulatory Therapy
by: I-Ni Hsieh, et al.
Published: (2016-09-01)

The serum level of the immunomodulatory peptide cathelicidin LL37 and T helper cell type 1 inflammatory response in viral hepatitis B, C, and D
by: Iacob Simona Alexandra, et al.
Published: (2013-03-01)

Anti-Carbamylated LL37 Antibodies Promote Pathogenic Bone Resorption in Rheumatoid Arthritis
by: Liam J. O’Neil, et al.
Published: (2021-09-01)

Etiopathogenesis and Diagnostic Strategies in Autoimmune Hepatitis
by: Weronika Domerecka, et al.
Published: (2021-08-01)

Prediction of recurrent currents of tooth decay among pregnant women laboratory method evaluation of antimicrobial activity of immunity oral liquid
by: V. A. Prohodnaja, et al.
Published: (2015-04-01)

Complexation of fungal extracellular nucleic acids by host LL-37 peptide shapes neutrophil response to Candida albicans biofilm
by: Magdalena Juszczak, et al.
Published: (2024-02-01)

Lactobacilli Downregulate Transcription Factors in <i>Helicobacter pylori</i> That Affect Motility, Acid Tolerance and Antimicrobial Peptide Survival
by: Fanglei Zuo, et al.
Published: (2022-12-01)

Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections
by: Bapi Pahar, et al.
Published: (2020-09-01)

Structural Plasticity of LL-37 Indicates Elaborate Functional Adaptation Mechanisms to Bacterial Target Structures
by: Kornelius Zeth, et al.
Published: (2021-05-01)

Efficacy of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model
by: Oriana Simonetti, et al.
Published: (2021-10-01)

Altered Expression of Antimicrobial Peptides in the Upper Gastrointestinal Tract of Patients with Diabetes Mellitus
by: Oliver Linn, et al.
Published: (2023-02-01)

Editorial: The role of neutrophils and its NETosis in autoimmunity and autoinflammation
by: François Niyonsaba, et al.
Published: (2022-10-01)

Thalidomide Attenuates Skin Lesions and Inflammation in Rosacea-Like Mice Induced by Long-Term Exposure of LL-37
by: Kang Y, et al.
Published: (2022-12-01)

LL37 Inhibits Aspergillus fumigatus Infection via Directly Binding to the Fungus and Preventing Excessive Inflammation
by: Xiao-Li Luo, et al.
Published: (2019-02-01)

Association of vitamin D3, VDR gene polymorphisms, and LL-37 with a clinical form of Chagas Disease
by: Luiz Roberto de Oliveira Junior, et al.

The potentials of short fragments of human anti-microbial peptide LL-37 as a novel therapeutic modality for diseases
by: Keqiang Chen, et al.
Published: (2021-11-01)

Cathelicidin preserves intestinal barrier function in polymicrobial sepsis
by: Jeffery Ho, et al.
Published: (2020-02-01)

Cutaneous antimicrobial peptides: New “actors” in pollution related inflammatory conditions
by: Brittany Woodby, et al.
Published: (2021-05-01)

Evaluation of LL 37 Lipoprotein As Innate Immunity Marker among Sudanese Patients Cutaneous Leishmania
by: Ayat H. Bakr, et al.
Published: (2019-09-01)

Citrullination Alters the Antiviral and Immunomodulatory Activities of the Human Cathelicidin LL-37 During Rhinovirus Infection
by: Víctor Casanova, et al.
Published: (2020-02-01)

Enhanced antitumor effects by docetaxel/LL37-loaded thermosensitive hydrogel nanoparticles in peritoneal carcinomatosis of colorectal cancer
by: Fan R, et al.
Published: (2015-12-01)

The human cathelicidin antimicrobial peptide LL-37 and mimics are potential anticancer drugs
by: Kengo eKuroda, et al.
Published: (2015-06-01)

A positive feedback loop between mTORC1 and cathelicidin promotes skin inflammation in rosacea
by: Zhili Deng, et al.
Published: (2021-05-01)

Long-Term Administration of LL-37 Can Induce Irreversible Rosacea-like Lesion
by: Chuanxi Zhang, et al.
Published: (2023-03-01)

<u>Hi</u>gh-<u>T</u>hroughput <u>C</u>AMP <u>A</u>ssay (HiTCA): A Novel Tool for Evaluating the Vitamin D-Dependent Antimicrobial Response
by: Carter Gottlieb, et al.
Published: (2023-03-01)

LL-37 Triggers Antimicrobial Activity in Human Platelets
by: Francisco Javier Sánchez-Peña, et al.
Published: (2023-02-01)

Influence of Vitamin D Deficiency on the Level of Salivary cathelicidin LL-37 in relation to Dental Caries Experience: A Case-Control Study
by: Narjes M. Alhelfi, et al.
Published: (2023-04-01)

The Human Antimicrobial Peptides Dermcidin and LL-37 Show Novel Distinct Pathways in Membrane Interactions
by: Kornelius Zeth, et al.
Published: (2017-11-01)

Cathelicidin Mediates an Anti-Inflammatory Role of Active Vitamin D (Calcitriol) During M. paratuberculosis Infection
by: Joseph A. Vaccaro, et al.
Published: (2022-04-01)

Cord blood antimicrobial peptide LL37 levels in preterm neonates and association with preterm complications
by: Zhuxiao Ren, et al.
Published: (2022-07-01)

Murine and Human Cathelicidins Contribute Differently to Hallmarks of Mastitis Induced by Pathogenic Prototheca bovis Algae
by: Muhammad Shahid, et al.
Published: (2020-02-01)

Evaluation of host defense peptide (CaD23)-antibiotic interaction and mechanism of action: insights from experimental and molecular dynamics simulations studies
by: Ting, Darren Shu Jeng, et al.
Published: (2022)